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ABSTRACT 
Mutations in the skeletal muscle ryanodine 
receptor gene (RYR1) can cause 
susceptibility to malignant hyperthermia 
(MH), a potentially lethal genetic condition 
triggered by volatile anesthetics. MH is 
associated with hypermetabolism which has 
directed research interest into oxidative 
phosphorylation (OXPHOS) and muscle 
bioenergetics. The most common cause of 
MH in the United Kingdom is the c.7300G>A 
RYR1 variant, which is present in ~16% of 
MH families. Our study focuses on the MH 
susceptible G2435R-RYR1 knock-in mouse 
model, which is the murine equivalent of the 
human c.7300G>A genotype. We 
investigated bioenergetics in this mouse 
model using a combination of 
transcriptomics, protein expression and 
functional analysis using adult muscle fibers. 
RNA sequencing data showed reduced 
expression of genes associated with 
mitochondria and fatty acid oxidation in 
RYR1 mutants when compared to wild-type 
(WT). Mitochondrial function was assessed 
by measuring oxygen consumption rates in 
permeabilized muscle fibers. Comparisons 
between WT and homozygous G2435R-
RYR1 mitochondria showed a significant 
increase in complex I-facilitated OXPHOS in 
mutant muscle. Furthermore, a gene-dose 
specific increase in reactive oxygen species 
production was seen in G2435R-RYR1 
muscle fibers. Collectively these findings 
provide evidence of metabolic defects in 
G2435R-RYR1 knock-in mouse muscle 
under basal conditions. Differences in 
metabolic profile could be the result of 
differential gene expression in metabolic 
pathways, in conjunction with mitochondrial 
damage accumulated from chronic exposure 
to increased oxidative stress. 
 
INTRODUCTION 
The ryanodine receptor isoform 1 (RyR1), is a 
calcium release channel expressed 
predominantly in the sarcoplasmic reticulum 
(SR) of skeletal muscle. Mutations in the RYR1 
gene result in dysregulation of intracellular 
Ca2+ homeostasis and are the primary genetic 
cause for malignant hyperthermia (MH) 
susceptibility, a dominantly inherited disorder 
which presents with potentially fatal 
hypermetabolic reactions after exposure to 
volatile anesthetic agents or succinylcholine 
(1). Clinical diagnosis of MH susceptibility 
uses a combination of genetic screening and 
pharmacological challenge testing (2). At 
present, the European Malignant Hyperthermia 
Group (EMHG) recognises 48 functionally 
characterized RYR1 variants for use in 
prospective DNA diagnosis of MH 
(www.emhg.org). Within this list, the RYR1 
c.7300G>A variant, is the most prevalent 
within the United Kingdom, found in almost 
16% of MH families (3). This missense variant 
results in a p.Gly2434Arg amino acid change 
which, despite being the most common variant, 
generally presents with a weaker phenotype 
compared to other variants (4). Given its 
prevalence, a new mouse RyR1 knock-in model 
(G2435R-RYR1), equivalent to the human 
c.7300G>A genotype, was recently developed 
to further our understanding of MH (5).  
Individuals who are susceptible to MH  
may have no phenotype without exposure to 
anesthesia or can present with a range of 
muscle-related features such as myopathy, 
exertional heat illness, rhabdomyolysis, 
exercise intolerance, weakness and cramping 
(6,7). While the primary feature of the 
hypermetabolic reaction during anesthesia is a 
massive increase in [Ca2+]i, mitochondrial 
dysfunction, which has been found in other MH 
mouse models (Y522S-RYR1, R163C-RYR1 
and T4826I-RYR1) (8-10), may contribute to 
the non-anesthesia phenotypes.  
Structural anomalies such as 
mitochondrial swelling and deformation, which 
appear to increase in severity with age, have 
been observed in homozygous (HOM) T4826I-
RYR1 and heterozygous (HET) Y522S-RYR1 
mice (8,11,12). Evidence of reduced 
mitochondrial content has been seen in all HET 
RYR1 knock-in MH mouse models 
investigated (9-11). The mitochondrial injury 
observed in HET Y522S-RYR1 and HET 
R163C-RYR1 muscle has been attributed to 
increased oxidative stress due to increased 
production of reactive oxygen species (ROS) 
(8,9,13). All of these murine models have also 
been shown to have hypermetabolism after 
exposure to an anesthetic challenge and 
elevated resting calcium ([Ca2+]rest) in their 
skeletal muscle fibers (12,14,15). 
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However, there are limitations in the 
methods previously used to study 
mitochondrial function. Studies using isolated 
mitochondria are limited by the absence of their 
normal cellular environment and lack of 
interaction with other organelles. This can be 
detrimental in the study of conditions such as 
MH since it is intimately dependent on SR 
function and calcium regulation. Likewise, 
mitochondrial studies in cultured myotubes, 
which are immature myofiber precursors, have 
limitations because of differences in their 
calcium signalling and organelle structure 
compared to adult muscle fibers (16,17). Here 
we have conducted a study to investigate 
bioenergetics in the G2435R-RYR1 MH-
susceptible (MHS) mouse model using a 
combination of transcriptomics, protein 
expression and muscle fiber functional analysis. 
Similar to previously characterized RYR1 
knock-in mouse models, HET and HOM 
G2435R-RYR1 mice have elevated [Ca2+]rest 
and fulminant MH reactions in response to 
anesthetic exposure (5).  We performed 
respirometry and real-time oxidative stress 
analysis on adult muscle fibers allowing 
measurements to be made within the context of 
native muscle structure and signalling 
properties. We hypothesized that G2435R-
RYR1 mouse muscles will exhibit differential 
gene expression governing metabolic pathways 
which contribute towards mitochondrial 
dysfunction. We used HET T4826I-RYR1 
knock-in mice for comparison, as they are a 
well-documented model with previously 
demonstrated alterations in their metabolic 
profile (10,12). 
RESULTS  
Differential gene expression 
RNAseq was performed on polyA selected 
mRNA samples extracted from wild-type 
(WT), G2435R-RYR1 HET, G2435R-RYR1 
HOM and T4826I-RYR1 HET mice. A sample-
sample distance heatmap (Figure 1A) was used 
to visualize overall gene expression between 
samples and through the dendrogram we can 
see clustering of WT and G2435R-RYR1 HET 
samples showing a close relationship between 
these two genotypes. In contrast, the T4826I-
RYR1 HET samples formed their own distinct 
cluster alongside a pair of G2435R-RYR1 
HOM samples which suggests that these two 
genotypes have more divergent transcriptome 
profiles than G2435R-RYR1 HETs in 
comparison to WT. Principal component 
analysis (PCA) (Figure 1B) displays highest 
degrees of variability between the T4826I-
RYR1 HET and G2435R-RYR1 HOM samples 
as shown by the distant clustering on the PC1 
axis (31% variance). Variability on the PC2 
axis is greatest within the G2435R-RYR1 HOM 
genotype as one sample does not seem to cluster 
(26% variance).  
Transcriptomes from each RYR1 
knock-in genotype were compared to WT to 
identify differentially expressed genes. 
Differences with an adjusted p value <0.05 
were considered significant following the 
protocol outlined in the DESeq2 R package. In 
the WT vs G2435R-RYR1 HOM and WT vs 
T4826I-RYR1 HET comparisons, a cohort of 
393 (98 upregulated, 295 downregulated) and 
206 (82 upregulated, 124 downregulated) 
differentially expressed genes were found, 
respectively. In contrast, the WT vs G2435R-
RYR1 HET knock-in comparison showed only 
one gene differentially expressed, Blvrb, which 
was found to be upregulated in all RYR1 
knock-in genotypes.  
Pathway and Gene Ontology analysis 
Pathway and gene ontology analyses were 
conducted on WT vs G2435R-RYR1 HOM and 
WT vs T4826I-RYR1 HET gene lists. Pathway 
analysis of downregulated genes in the WT vs 
G2435R-RYR1 HOM comparison showed a set 
of seven significantly enriched pathway terms, 
many of which are involved in cellular energy 
production (Table 1). Within this set, five 
SDWKZD\ WHUPV µ)DWW\ DFLG EHWD-oxidation 
:3¶ µ0LWRFKRQGULDO/&-Fatty acid beta-
R[LGDWLRQ :3¶ µ)DWW\ DFLG ELRV\QWKHVLV
:3¶µ7&$&\FOH:3¶DQGµ)DWW\DFLG
R[LGDWLRQ :3¶ ZHUH DOVR IRXQG
downregulated in the WT vs T4826I-RYR1 
HET comparison, but only the last term was 
statistically significant. The gene ontology 
analysis of downregulated genes showed that 
the top 10 enriched biological processes from 
the WT vs G2435R-RYR1 HOM comparison, 
were all involved in either fatty acid oxidation 
or fatty acid transport into mitochondria (Table 
2). The gene ontology analyses of 
downregulated genes in the WT vs T4826I-
RYR1 HET gene list shared several of the same 
terms surrounding fatty acid metabolism but 
were not statistically significant (adjusted p 
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value > 0.05) (Table 2). The only shared 
observation between the WT vs G2435R-RYR1 
HOM and the WT vs T4826I-RYR1 HET 
comparisons was an enrichment of genes in the 
cellular component gene ontology terms 
µ0LWRFKRQGULRQ¶ DQG µ0LWRFKRQGULDO PDWUL[¶
(Tables S1, S2). The WT vs G2435R-RYR1 
HOM comparison featured the highest number 
of differentially expressed genes in the 
µ0LWRFKRQGULRQ¶WHUP$PRQJWKHVHJHQHVRI
LQWHUHVWLQFOXGHµNdufs1¶µNdufs2¶µSdha¶DQG
µUqcrc2¶ ZKLFK HQFRGH IRU PLWRFKRQGULDO
complex I, II and III of the electron transport 
chain (Table S1). In contrast, analysis of 
upregulated genes from each comparison 
showed no significant enrichment of pathways 
and gene ontology terms, aside from a few 
cellular component gene ontology terms found 
in the WT vs G2435R-RYR1 HOM comparison 
(Tables S3, S4).  
Respirometry 
Mass-specific oxygen consumption rate (OCR) 
(pmol/s*mg) significantly differed among 
RYR1 genotypes in the LEAK (p<0.001), 
CI+CII(ETS) (p=0.024) and CIV(MAX) (p=0.017) 
states. Post hoc pairwise comparisons (Figure 
2A) between WT and G2435R-RYR1 HETs 
showed no significant differences, while the 
G2435R-RYR1 HOMs differed only in 
CIV(MAX) with significantly lower output than 
WT (p=0.027). This finding suggests that 
G2435R-RYR1 HOM skeletal muscle fibers 
may have a lower mitochondrial content than 
WT fibers. T4826I-RYR1 HET knock-ins had 
lower oxygen flux in LEAK (p<0.01 against all 
genotypes) and a greater electron transport 
system (ETS) capacity (CI+CII(ETS)) compared 
to G2435R-RYR1 HOM mice (p=0.023). 
Oxygen flux was then normalized to a 
common reference state, CI+CII(ETS), to obtain 
flux control ratios (FCR) (Figure 2B). These 
ratios provide a measure of function as a 
proportion of ETS capacity, which is 
independent of mitochondrial content. In 
contrast to raw data, comparison of normalized 
data showed that FCR differed significantly 
among RYR1 genotypes in the LEAK, 
CI(OXPHOS) and CI+CII(OXPHOS) states (all 
p<0.001). Pairwise FCR comparisons within 
the LEAK state did not differ from raw data 
after normalization. However, CI(OXPHOS) FCR 
showed significantly higher values in G2435R-
RYR1 HOM compared to WT (p=0.014), 
suggesting a greater reliance on complex I 
function as it forms a higher proportion of the 
ETS capacity. This effect appears to carry over 
to the CI+CII(OXPHOS) combined state which is 
also significantly higher in G2435R-RYR1 
HOM (p=0.004). On the other hand, T4826I-
RYR1 HET knock-ins showed significantly 
lower CI(OXPHOS) and CI+CII(OXPHOS) FCR in 
comparison to G2435R-RYR1 HET and HOM 
knock-ins which implies that different RYR1 
variants can alter skeletal muscle mitochondrial 
function in different ways.  
Oxidative stress and protein expression 
ROS generation in fibers with exposure to 
hydrogen peroxide (H2O2) was assessed using 
the CellROX Green reagent. The increase in the 
CellROX Green fluorescence signal intensity 
generated over 30 minutes after treatment with 
1 mM H2O2 was significantly different among 
genotypes (Figure 3A, B). The two-way mixed 
ANOVA showed a significant interaction 
between genotype and time on ROS generation, 
F(10, 480) = 13.05, p < 0.001. When compared 
to WT mice, G2435R-RYR1 HOM mice 
showed significant increase in ROS at each 
time point and significant differences were seen 
in G2435R-RYR1 HET mice at 20 mins and 
beyond (Figure 3A). Area under the curve 
analysis showed that the area for WT fibers 
(106133±10923) was significantly less than for 
either G2435R-RYR1 HET (154722±17844, 
p=0.028) or G2435R-RYR1 HOM 
(212481±11617, p=0.013) fibers. Comparisons 
between HET and HOM G2435R-RYR1 
knock-ins also showed a significant difference 
(p=0.008) related to gene dose (Figure 3B).  
Western blots quantifying citrate 
synthase expression, a marker for 
mitochondrial content (Figure 3C) showed no 
significant differences between genotypes at 
the protein level (WT vs. HET p=0.997, HET 
vs. HOM p=0.878, WT vs. HOM p=0.911). 
Based on their important roles in the ROS 
pathway we measured the expression of both 
NADPH-oxidase 2 (NOX2) and superoxide 
dismutase 1 (SOD1). NOX2 catalyses the 
reduction of molecular oxygen into superoxide 
ions and SOD1 is responsible for their 
breakdown (18). NOX2 expression levels were 
significantly higher in G2435R-RYR1 HOM vs 
WT muscle (0.74±0.07 vs 0.44±0.07, p= 
p=0.047) (Figure 3D). In contrast, the opposite 
was seen with SOD1, which was significantly 
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decreased in G2435R-RYR1 HOM in 
comparison to WT muscle (0.68±0.08 vs 
0.33±0.08, p=0.017 Figure 3E). Interestingly 
despite the difference in the slopes of the 
increase in CellROX Green intensity, neither 
NOX2 nor SOD1 protein expression in 
G2435R-RYR1 HET muscle was significantly 
different than WT (NOX2 WT vs. HET p=0.08, 
SOD1 WT vs. HET p=0.25). 
Discussion 
Transcriptome profiles between WT and RYR1 
knock-in mice revealed differential gene 
expression at rest. Gene expression profiles 
between WT and G2435R-RYR1 HET mice 
show great similarity while G2435R-RYR1 
HOM and T4826I-RYR1 HET comparisons 
featured several hundred differentially 
expressed genes when compared to WT. This 
disparity demonstrates that RYR1 mutations 
can impact skeletal muscle gene expression in a 
variant-specific manner.  
Pathway and gene ontology analysis 
found that a large proportion of downregulated 
genes in G2435R-RYR1 HOM and T4826I-
RYR1 HET knock-in muscles were localized in 
mitochondria, many of which were responsible 
for regulating fatty acid metabolism. Free fatty 
acids (FFA) are an important source of energy 
in muscle. They are metabolized by first 
XQGHUJRLQJ ȕ-oxidation to generate acetyl-
CoA, which is a substrate for the Krebs cycle in 
the mitochondrial matrix (19). Impaired fatty 
acid oxidation and transport, results in the 
accumulation of FFA in skeletal muscle which 
causes lipotoxicity - associated with insulin 
resistance, oxidative stress and mitochondrial 
dysfunction (19-21). This appears to be a 
mutant RYR1-related phenotype since several 
of the genes related to this process (Acadm, 
Decr1 and Etfa) were shared between the WT 
vs G2435R-RYR1 HOM and WT vs T4826I-
RYR1 HET comparisons. Furthermore, it was 
previously speculated that there is reduced fatty 
acid oxidation in the R163C-RYR1 knock-in 
mouse model because there is reduced 
expression of enzymes which regulate this 
process in R163C mitochondria (9,22).  
The human orthologues of 
differentially expressed genes found in 
G2435R-RYR1 HOM (Acadm, Acadvl, Hadha, 
Hadhb, Cpt2, Etfa, Etfdh), and T4826I-RYR1 
HET mouse muscle (Acadm, Etfa) are 
associated with fatty acid oxidation disorders 
(23). Connections between FFA and MH 
pathology were first described in MH 
susceptible pigs after significantly higher levels 
of FFA and phospholipase activity were found 
in mitochondria (24-26). Several years later, 
elevated FFA production in MH susceptible 
human muscle was linked to increased 
sensitivity to halothane (27-29). It was 
hypothesized that FFA and lipid peroxidation 
contributed to calcium dysregulation by 
inducing calcium release from the SR, with 
potential to modulate the MH phenotype 
(6,24,25,30). The results seen in our RNAseq 
analysis suggest that this line of research 
warrants further investigation. Although Blvrb 
was the only transcript upregulated in all three 
RYR1 knock-ins tested, it does not participate 
in any of the enriched pathways and gene 
ontology terms identified and is therefore 
unlikely to represent a common mechanistic 
link across the genotypes studied. Blvrb 
encodes a protein associated with heme 
metabolism and redox regulation (31,32) and its 
upregulation is consistent with a response to 
increased oxidative stress in all genotypes. 
Other areas of interest regarding 
specific genes include the downregulation of 
Ndufs1 and Ndufs2 (encoding complex I), Sdha 
(encoding complex II) and Uqcrc2 (encoding 
complex III) which were found to be 
differentially expressed in the WT vs G2435R-
RYR1 HOM comparison. Reduced gene 
expression of mitochondrial complexes 
suggests multicomplex impairment of the 
electron transport chain due to an imbalance in 
turnover. Investigation into mitochondrial 
function using high resolution respirometry 
showed significant functional differences in 
G2435R-RYR1 HOM and T4826I-RYR1 HET 
genotypes. The results from two different 
markers for mitochondrial content were not 
consistent in our study, as citrate synthase 
protein expression showed no differences 
between genotype while the mass-specific 
complex IV assay (CIV(MAX)) output suggested 
evidence of lower mitochondrial content in 
G2435R-RYR1 HOM muscle (33). However, 
we did not see this change in G2435R-RYR1 
HET and T4826I-RYR1 HET muscles despite 
evidence in previous studies that the latter had 
lower mitochondrial content (10).  
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The LEAK FCR provide an indication 
of ETS uncoupling, reflecting the proportion of 
ETS capacity related to non-phosphorylating 
respiration (proton leakage). Comparison of 
LEAK FCR show that mitochondria from both 
G2435R-RYR1 HET and HOM genotypes have 
normal ETS coupling efficiency compared to 
WT, whilst T4826I-RYR1 HETs have a lower 
LEAK FCR indicating higher ETS coupling 
efficiency. This was surprising as MHS muscle 
is often associated with mitochondrial 
uncoupling at rest (9,34,35). The elevated 
CI(OXPHOS) FCR observed in G2435R-RYR1 
HOM mice suggests they are more reliant on 
complex I function as it takes up a higher 
proportion of the ETS capacity. This is thought 
to be due to an increase in electron flow through 
complex I, which may be an adaptation to 
compensate for lower mitochondrial content 
and to maintain the energy demands of the 
muscle.  
Compared to both G2435R-RYR1 
genotypes, the electron flow through complex I 
in phosphorylating states were lower in T4826I-
RYR1 HETs. WT vs T4826I-RYR1 HET 
comparisons were not significantly different, 
and this may have been due to compensation by 
the increased ETS coupling efficiency 
observed. In a previous study of T4826I-RYR1 
mitochondrial function in myotubes using 
Seahorse® technology, a reduction in basal 
respiration and ETS capacity was reported but 
this was not observed in our findings (10). 
These contrasting results between studies is 
perhaps due to methodological differences in 
addition to our use of adult muscle fibers as 
opposed to cultured myotubes.    
Consistent with studies of other MH 
susceptible RYR1 knock-in mice, we have 
shown that both HET and HOM G2435R-
RYR1 muscle have elevated levels of oxidative 
stress (8,9,12,36). Two major oxidative stress 
proteins NOX2 and SOD1 were quantified and 
their differences in expression suggest that 
there is an elevated baseline level of superoxide 
ions in the G2435R-RYR1 muscles that is the 
result of both increased superoxide production 
and a reduced ability to metabolise it. In 
addition, the increased FCR in complex I of the 
G2435R-RYR1 HOM mice may lead to 
increased superoxide production as it is one of 
the main sources of superoxide in the 
mitochondria (37,38).  Superoxide will likely 
damage cells and impair function which may 
explain the deficient and swollen mitochondria 
described in other RYR1 knock-in MH mouse 
models (5,8). Our study also shows that 
G2435R-RYR1 HOM and HET mice have a 
significant and gene-dose dependent elevation 
of CellROX Green detected ROS production in 
response to H2O2 induced oxidative stress 
compared to WT mice. The increase in ROS 
level has been attributed to an elevation in 
superoxide and/or hydroxyl radicals, as 
CellROX Green is found to be reactive to both 
species, but not H2O2 (39-41). A decrease in 
antioxidant capacity, in combination with an 
increase in ROS production could be 
responsible for the higher levels of oxidative 
stress in G2435R-RYR1 mice  (37,42).  
The lack of differences seen in gene 
expression and mitochondrial function between 
WT and G2435R-RYR1 HET mice, highlights 
the complexity of the MH phenotype. 
Individuals with the equivalent c.7300G>A 
human MH variant are generally associated 
with weaker clinical phenotypes and our 
observations with G2435R-RYR1 HET mice 
reflect this (4). The metabolic phenotype in MH 
is complicated but most of the evidence 
suggests bioenergetic impairment in 
susceptible individuals. Here we have 
demonstrated evidence of mitochondrial 
dysfunction and increased oxidative stress in 
the G2435R-RYR1 knock-in mouse model. 
These outcomes have likely been perpetuated 
by elevated [Ca2+]rest and possible deficiencies 
in fatty acid metabolism, both of which are 
heavily involved in regulating muscle 
bioenergetics. Given its complex nature, future 
research exploring fatty acid metabolism and 
glycolysis would be ideal for a more 
comprehensive view of how RYR1 mutations 
affect metabolism in skeletal muscle.  
 
EXPERIMENTAL PROCEDURES  
Animals 
Animals were housed in pathogen-free 
conditions with free access to food, water and 
12 hr light-and-dark cycles. All experiments 
were undertaken with UK Home Office 
approval. For transcriptomics, 8 weeks old male 
mice were used while a mixture of male and 
female mice between 8-14 weeks old were used 
for functional studies.  
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Preparation of samples for RNA sequencing 
WT mice for sequencing were created within 
the G2435R-RYR1 colony by breeding HET 
mice together. A total of 12 mice of four 
genotypes - WT, G2435R-RYR1 HET, 
G2435R-RYR1 HOM and T4826I-RYR1 HET 
knock-ins (age 8 weeks, n=3 for each genotype) 
were killed by cervical dislocation. Hind limbs 
were removed and kept in oxygenated Krebs 
ringer solution for 30 min at 37 oC before soleus 
muscles were dissected and transferred into 
RNAlater (INVITROGEN) at -80 oC until 
further processing.  
The stored soleus muscles were 
homogenized in 1 ml TRIzol© and RNA was 
extracted using a chloroform/isopropanol 
extraction method, followed by an RNA clean 
up step using the RNAeasy microkit (QIAGEN) 
with on-column DNase treatment, according to 
PDQXIDFWXUHU¶V LQVWUXFWLRQV7KH$JLOHQW
Tapestation was then used to assess RNA 
integrity. RNA samples with integrity scores of 
RINe >7.0 were considered acceptable for 
sequencing.  
Truseq® Stranded mRNA library 
preparation 
PolyA selected mRNA libraries were created 
from the isolated RNA by the Next Generation 
Sequencing )DFLOLW\ DW 6W -DPHV¶V +RVSLWDO
Leeds. RNA samples were first quantified using 
WKH4XELW51$%5$VVD\.LW,QYLWURJHQ
before being used to create libraries using the 
Truseq Stranded mRNA library preparation kit 
,OOXPLQD DFFRUGLQJ WR PDQXIDFWXUHU¶V 
guidelines. All cDNA libraries were finally 
quality checked using the Agilent D1000 
screentape and quantified using the Quant-L7
PicoGreen® dsDNA assay. 
Illumina® HiSeq® NGS 
Twelve mRNA-enriched libraries were indexed 
and compiled into a single pool at equimolar 
concentrations. This library pool was then 
distributed across two HiSeq 3000 150-bp 
paired-end lanes, achieving an average of 25M 
reads per sample. A forward and reverse 
FASTQ file was generated for each sample on 
each lane. 
Differential gene expression analysis 
Raw sequencing data (FASTQ files) were 
initially processed using the Medical Advanced 
Research Computer (MARC1) - a high-
performance computer cluster at the University 
of Leeds. The FASTQ files for each technical 
replicate across HiSeq lanes were combined 
DQG WULPPHG XVLQJ ³&XWDGDSW´ WR UHPRYH
adapters and bad quality base calls (<10) (43). 
Quality assessment before and after trimming 
was performed using FastQC 
(https://www.bioinformatics.babraham.ac.uk/p
rojects/fastqc/) (44). All samples were aligned 
using the STAR aligner and quantified using 
featureCounts (45,46). Processed sequencing 
data was then imported into RStudio and 
analysed using the DESeq2 package for 
differential gene expression (47,48).  
Pathway and gene ontology 
Lists of differentially expressed genes, 
generated from DESeq2, were functionally 
characterised to identify enriched pathway 
terms. This was achieved using the online 
enrichment analysis tool Enrichr(49,50). Gene 
lists were compared to 176 pathway terms in the 
³:LNL3DWKZD\VBB0RXVH´JHQH-set library 
with a gene coverage of 4558 genes.  
Further enrichment analysis of gene ontology 
terms utilised the following gene-set libraries: 
³*2B%LRORJLFDOB3URFHVVB´WHUPV
14433 gene coverage), 
³*2B0ROHFXODUB)XQFWLRQB´WHUPV
11459 gene coverage), 
³*2B&HOOXODUB&RPSRQHQWB´WHUPV
8655 gene coverage).  
Muscle sample preparation for respirometry  
WT (n=16) and RYR1 knock-in mice 
(G2435R-RYR1 HET, n=16; G2435R-RYR1 
HOM, n=16; T4826I-RYR1 HET, n=12; age 8-
12 weeks) were killed by cervical dislocation 
and soleus muscles were rapidly dissected from 
their hind limbs and placed into 1 ml of ice-cold 
biopsy preservation buffer, BIOPS (2.77 mM 
CaK2EGTA, 7.23 mM K2EGTA, 5.77 mM 
Na2ATP, 6.56 mM MgCl2·6H2O, 20 mM 
taurine, 15 mM Na2Phosphocreatine, 20 mM 
imidazole, 0.5 mM dithiothreitol (DTT), and 50 
mM MES hydrate, pH 7.1, adjusted with 5 N 
KOH at 0 °C) immediately after collection for 
storage and transport. Muscle fiber bundles 
containing approximately 4-5 fibers each were 
mechanically separated from the intact muscles 
using sharp forceps. These fiber bundles then 
underwent chemical permeabilization in ice 
FROG%,236FRQWDLQLQJVDSRQLQȝJāPO-1) for 
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30 min, before being washed with 1 ml 
respiration medium, Mir05 (0.5 mM EGTA, 3 
mM MgCl2·6H2O, 60 mM lactobionic acid, 20 
mM taurine, 10 mM KH2PO4, 20 mM HEPES 
adjusted to pH 7.1 with KOH at 37 °C, 110 mM 
D-sucrose, and 1 g·L-1 essentially fatty acid free 
BSA) to remove residual saponin. The sample 
was then blot-dried for 5 s, weighed and loaded 
into a respirometer chamber (1-2 mg in each 
chamber) containing 2 ml of Mir05. The time 
between biopsy collection and assay was 90 ± 
120 min (35,51). 
High Resolution Respirometry  
Oxygen consumption over time was measured 
using Oroboros respiratory analysers (Oroboros 
Instruments, Innsbruk, Austria) at 2 s intervals 
with polarographic oxygen sensors and expressed 
as mass-specific oxygen flux (pmol/s*mg). The 
analyser was calibrated daily in air saturated 
solution before experimentation. Assays were 
initiated by injecting oxygen into each chamber 
to raise the oxygen concentration to > 400 
nmol/mL prior to starting a substrate-
uncoupler-inhibitor titration (SUIT) protocol. 
Re-oxygenation of the chambers was 
performed to maintain oxygen concentration 
between 200-500 nmol/mL to prevent 
limitation due to oxygen diffusion (51). Each 
assay was performed at 37 °C, with chamber 
stirrers set at 750 rpm.  
SUIT protocol 
Reagents and inhibitors were sequentially 
added into the reaction chambers in the order 
displayed (Table 3). The composition of each 
respiratory state (in bold) are as follows - 
LEAK: (B, G, M, P), CI(OXPHOS): (LEAK + 
ADP), CI+CII(OXPHOS): (LEAK + ADP + CC + 
S), CI+CII(ETS): (LEAK + ADP + CC + S + 
FCCP), CII(ETS): (LEAK + ADP + CC + S + 
FCCP + R), ROX: (LEAK + ADP + CC + S + 
FCCP + R + AA). The ROX state represented 
residual oxygen consumption outside of 
mitochondrial function and is therefore 
subtracted from the other states to obtain final 
readings (35,51,52). 
Complex IV Assay (CIVMAX) 
Measurement of mass-specific complex IV 
oxygen flux was used as an alternative proxy 
marker for estimations of mitochondrial 
FRQWHQW $VFRUEDWH  P0 DQG 111ƍ1ƍ-
tetramethyl-p-phenylenediamine (TMPD) (0.5 
mM) were applied to each sample at the end of 
the standard SUIT protocol (33). The 
measurement of CIV(MAX) is taken at the peak of 
the corresponding trace and residual chemical 
background is finally removed from this value 
by applying sodium azide (10 mM) to the 
sample. 
Adult Single Fiber Preparation 
Single fibers were isolated from flexor 
digitorum brevis (FDB) muscles using 
collagenase digestion (53). FDB muscles were 
incubated at 37°C, 5% CO2 in culture medium 
containing 0.2% (wt/vol) collagenase type I 
(Abnova, Taiwan, China), 0.4% Bovine Serum 
Albumin (Sigma, St. Louis, Missouri, USA) for 
2.5 h. Following incubation, fibers were 
separated by gentle trituration in 3 ml of 
collagenase-free culture DMEM (Gibco, 
Burlington, Canada) containing 100 units/ml of 
SHQLFLOOLQ DQG  ȝJPO RI VWUHSWRP\FLQ
(Gibco, Burlington, Canada), 10% heat 
inactivated FBS (Gibco, Burlington, Canada). 
Fibers were then allowed 30 min to settle on 96 
well plates coated with Cultrex basement 
membrane matrix (Trevigen, Minneapolis, 
USA).  
CellROX Green ROS assay 
CellROX Green dye 5 µM (Thermo 
Fisher Scientific) dissolved in mammalian 
Ringer solution (133 mM NaCl, 5 mM KCl, 1 
mM MgSO4, 10 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), 5.5 
mM glucose, 2 mM CaCl2 ) was applied to the 
dissociated fibers for 30 min at 37°C, 5% CO2. 
Fibers were washed twice with Ringer solution 
and then transferred to the stage of a Nikon 
TE2000 inverted microscope (Nikon, Tokyo, 
Japan). H2O2 1 mM dissolved in Ringer solution 
was perfused onto the fibers at ~100 Pl/s for 30 
s. CellROX Green was illuminated at 485nm 
with the X-Cite 120 metal halide light source 
(Exfo, Ontario, Canada) and fluorescence 
emission was measured at 520 nm using a 10X, 
0.3 na objective. The data were collected with 
an intensified 10-bit digital intensified CCD at 
1 fps (Stanford Phototronics, Stanford, CA) 
from 3-6 individual fibers and analysed using 
Piper image analysis software (Stanford 
Phototronics, Stanford, CA).  
Western blots 
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Mouse gastrocnemius muscle proteins were 
extracted using RIPA lysis buffer containing 25 
mM Tris, pH 7.6, 150 mM NaCl, 1% NP-40, 
0.1% sodium dodecylsulfate (SDS) (Thermo 
Fisher Scientific, Massachusetts, USA) 
containing 1X Halt Protease Cocktail (Thermo 
Fisher Scientific) at 1:10 w/v ratio and 
homogenized using a T10 basic Ultra Turrax 
(IKA, Oxford, UK) at 30,000 rpm for 1 min.  
The samples were then centrifuged at 11,337g 
in a microcentrifuge for 5 min and the 
supernatants were collected. Protein 
concentrations were quantified using a 
bicinchroninic acid assay (BCA) (Thermo 
Fisher Scientific). Equal quantities of total 
protein (20 µg) were loaded on a 15% 
denaturing polyacrylamide gel or a 4-20% 
Precast Mini-PROTEAN TGX polyacrylamide 
gel (Bio-Rad Laboratories, Herfordshire, UK) 
for electrophoresis. Following electroblotting, 
membranes were incubated with SOD1 
(ab13498, 1:250, Abcam, Cambridge, UK), 
NOX2 (ab129068, 1:500, Abcam, Cambridge, 
UK), citrate synthase (ab96600, 1: 500, Abcam, 
Cambridge, UK) primary antibodies. As a 
control, GAPDH antibody (ab9485, 1:2000, 
Abcam, Cambridge, UK) was used. HRP 
conjugated goat anti-rabbit IgG secondary 
antibody was then applied (ab6721,1: 2000, 
Abcam, Cambridge, UK). The protein bands 
were detected using a SuperSignal West Pico 
Plus ECL detection system (Thermo Fisher 
Scientific).  
Data handling and statistical analysis 
Gene expression data were analysed with the 
DESeq2 package which performs significance 
testing using a Wald test. This generates lists of 
differentially expressed genes with p values 
adjusted for multiple testing using the 
Benjamini-Hochberg (BH) adjustment (47,54). 
Pathway and gene ontology analysis of gene 
lists was done using Enrichr, which calculates 
enrichment scores using statistics based on the 
FishHU¶VH[DFWWHVW 
Respirometry data are presented either 
as oxygen flux per muscle mass (pmol/s*mg) or 
are normalized as flux control ratios which 
excludes the confounding effects of both 
mitochondrial quality and quantity. Oxygen 
flux readings were exported from specialised 
software DatLab5 (Oroboros Instruments, 
Innsbruk, Austria) into Microsoft Excel before 
analysis using SPSS statistics analysis software 
(Version 25.0. Armonk, New York, USA). 
Respirometry data were not normally 
distributed when assessed by the Shapiro Wilk 
test (p<0.05) and were subsequently analysed 
using a Kruskal-Wallis H test with a post hoc 
'XQQ¶V WHVW IRU SDLUZLVH FRPSDULVRQV 'DWD
were summarised as box plots using GraphPad 
Prism 8.  
CellROX Green ROS assay data are 
presented as mean fluorescence changes from 
baseline, normalised to WT fluorescence (F1-
F0). A two-way mixed ANOVA was used to 
investigate interaction effects between time and 
genotype on ROS production using SPSS 
statistics analysis software (Version 25.0. 
Armonk, New York, USA). One-way 
ANOVAs were used to compare the ROS 
differences between genotypes at each time-
point and pairwise comparisons were made 
using Tukey post hoc tests. Area under the 
curve calculations between WT, G2435R-
RYR1 HET and HOM mice were also 
compared using a one-way ANOVA with 
Tukey post hoc tests. 
Western blot band densities were 
obtained using ImageJ software and expression 
levels of the protein(s) of interest were 
normalised to the intensity of the GAPDH 
signal in the same lane. The normalised band 
densities for citrate synthase, SOD1 and NOX2 
were compared between WT, G2435R-RYR1 
HET and HOM mice using a one-way ANOVA 
with Tukey post hoc tests using SPSS statistics 
analysis software (Version 25.0. Armonk, New 
York, USA). 
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Figure 1. A) Expression heatmap of sample-to-sample distances as calculated from the variance-stabilizing transformation of count data for overall gene 
expression. Clustering of 12 RNA-seq samples gives an overview of relationships between genotypes, reflected by the intensity of square colours. B) PCA 
scatter plot of gene expression showing the variance among three biological replicates in each genotype. Percentages on each axis represent the percentages of 
variation explained by the principal components.
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Table 1. Pathway analysis using Enrichr. The top 10 downregulated pathways are shown for the WT 
vs G2435R-RYR1 HOM and WT vs T4826I-RYR1 HET comparisons, in combined score order (log of 
p-YDOXHIURP)LVKHU¶VH[DFWWHVWPXOWLSOLHGE\]VFRUHRIGHYLDWLRQIURPH[SHFted rank). This pathway 
analysis was produced using significantly downregulated genes (adjusted p-values <0.05) generated 
from DESeq2, as input for Enrichr. Statistically significant pathway terms are annotated with an asterisk 
(adjusted p-values <0.05).
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Table 2. Gene ontology enrichment analyses using Enrichr. The top 10 most enriched biological 
processes (GO_BP) are shown, generated using downregulated gene lists from both the WT vs G2435R-
RYR1 HOM and WT vs T4826I-RYR1 HET comparisons. Statistically significant ontology terms are 
annotated with an asterisk (adjusted p-value <0.05) Additional results from these analyses can be found 
in supporting information (Table S1-4).
(GO_BP) Biological Process Adjusted p-value Downregulated Genes
Fatty acid beta-oxidation (GO:0006635)* 8.84E-08
Abcd3, Acad11, Acadl, Acadm, Acadvl, 
Acat1, Decr1, Etfa, Etfdh, Hadha, Hadhb, 
Hsd17b4  
Fatty acid catabolic process (GO:0009062)* 1.05E-05 Abcd3, Acad11, Acadl, Acadm, Acadvl, Acat1, Decr1, Hadha, Hadhb, Hsd17b4, Mut  
Fatty acid oxidation (GO:0019395)* 1.50E-05 Abcd3, Acad11, Acadl, Acadm, Acadvl, Acat1, Decr1, Hadha, Hadhb, Hsd17b4  
Fatty acid beta-oxidation using acyl-CoA 
dehydrogenase (GO:0033539)* 8.25E-05 Acad11, Acadl, Acadm, Acadvl, Etfa, Etfdh   
Long-chain fatty acid transport (GO:0015909)* 2.62E-03 Acacb, Acsl1, Cd36, Cpt1b, Cpt2, Prkaa2     
Mitochondrial transmembrane transport 
(GO:1990542)* 9.58E-03
Acacb, Afg3l2, Cpt1b, Cpt2, Prkaa2, 
Timm29   
Fatty acid transmembrane transport (GO:1902001)* 1.17E-02 Acacb, Cpt1b, Cpt2, Prkaa2  
Carnitine shuttle (GO:0006853)* 1.33E-02 Acacb, Cpt1b, Cpt2, Prkaa2  
Regulation of fatty acid oxidation (GO:0046320)* 1.97E-02 Acadl, Acadvl, Lonp2, Mlycd
Regulation of acyl-CoA biosynthetic process 
(GO:0050812)* 2.19E-02 Dlat, Dld, Pdha1, Pdpr 
Fatty acid catabolic process (GO:0009062) 4.12E-01 Acadm, Decr1, Echs1, Nudt7,  Nudt19
Response to alkaloid (GO:0043279) 8.03E-01 Chrna1, Chrnd, Ryr1
Cardiolipin acyl-chain remodeling (GO:0035965) 8.38E-01 Lclat1, Taz
Fatty acid beta-oxidation (GO:0006635) 9.62E-01 Acadm, Decr1, Echs1, Etfa
Sarcoplasmic reticulum calcium ion transport 
(GO:0070296) 1.00E+00 Ryr1, Sln
Regulation of acyl-CoA biosynthetic process 
(GO:0050812) 1.00E+00 Dlat, Pdp1
Cardiolipin metabolic process (GO:0032048) 1.00E+00 Lclat1, Taz
Acetyl-CoA metabolic process (GO:0006084) 1.00E+00 Acss1, Nudt7
Regulation of acetyl-CoA biosynthetic process from 
pyruvate (GO:0010510) 1.00E+00 Dlat, Pdp1
Fatty acid beta-oxidation using acyl-CoA 
dehydrogenase (GO:0033539) 1.00E+00 Acadm, Etfa
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Gene ontology enrichment analyses of downregulated genes
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Figure 2. Boxplots summarizing respirometry data. These data were analysed using a Kruskal Wallis 
+WHVWZLWKSRVWKRF'XQQ¶VWHVWDQGVLJQLILFDQWSDLUZLVHFRPSDULVRQVDUHDQQRWDWHGZLWKDQDVWHULVNS
< 0.05). The top image A) shows mass-specific oxygen consumption rates in each genotype, and the 
bottom B) shows flux control ratios which represent the same set of data normalized to CI+CII(ETS) 
(dashed line).
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Figure 3. G2435R-RYR1 mice show increased oxidative stress. A) This graph shows fluorescence signal changes with 5µM CellROX Green fluorescent dye, which reflect 
ROS levels in FDB muscle fibers treated with 1mM of H2O2 for 30 minutes, normalised and compared to WT mice (n= 41 fibers from 4 mice for WT, n=28 fiber from 4 mice 
for G2435R-RYR1 HET, n=30 fibers from 3 mice for G2435R-RYR1 HOM in at least 5 independent experiments). Significant interactions between variables were assessed 
using a two-way mixed ANOVA before differences at each time point were analysed using a one-way ANOVA. Significant post hoc comparisons to WT are annotated using 
asterisks * p < 0.05, ** p < 0.01, *** p < 0.001. B) Comparison of area under curve from CellROX Green assay between G2435R-RYR1 HET, HOM and WT fibers. C), D) 
and E) Western blots showing Citrate Synthase, NOX2, SOD1 protein bands in mice gastrocnemius muscle respectively with the bar charts representing band densitometry 
intensities normalised to GAPDH signals and averaged WT signals (n= 3 mice for each genotype). Data represent mean ± S.E.M. These data were analysed using a one-way 
ANOVA and significant post hoc comparisons between genotypes are annotated with asterisks * p < 0.05, ** p < 0.01, *** p < 0.001. 
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Table 3. Chemical substrates and inhibitors used to activate different respiratory states within the SUIT 
protocol.
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